<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03245749</url>
  </required_header>
  <id_info>
    <org_study_id>RRD7/N02/A</org_study_id>
    <nct_id>NCT03245749</nct_id>
  </id_info>
  <brief_title>Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition</brief_title>
  <official_title>Effect of Oily Fish Intake, Sex, Age, BMI, and APOE Genotype on Plasma Long Chain n-3 Fatty Acid Composition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southampton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Food Standards Agency, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ocean Nutrition</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Southampton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of habitual oily fish intake, sex,
      age, BMI, and APOE genotype on plasma long chain n-3 fatty acid composition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The marine long chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs) eicosapentaenoic acid
      (EPA) and docosahexaenoic acid (DHA) are beneficial to cardiovascular and cognitive health
      and the concentration of EPA and DHA present in blood and tissue lipids is positively
      correlated with these effects.

      As a result, national and global authorities recommend regular consumption of oily fish in
      order to provide approximately 500 mg EPA+DHA per day in a healthy population. However, the
      associations between EPA and DHA intake and blood and tissue status, and therefore
      physiological benefits, are highly variable and the factors influencing this heterogeneity
      are not well understood.

      This study aims to investigate the effect of habitual oily fish intake as well as sex, age,
      BMI, and Apolipoprotein E (APOE) genotype on LC n-3 PUFA status in plasma
      phosphatidylcholine, non-esterified fatty acids, cholesteryl esters and triacylglycerols in
      order to obtain greater knowledge of the determinants of LC n-3 PUFA status with the
      potential to develop more robust, and perhaps subgroup specific, recommendations for EPA and
      DHA intake.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2003</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <primary_completion_date type="Actual">September 2005</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma long chain n-3 polyunsaturated fatty acid concentrations</measure>
    <time_frame>Baseline</time_frame>
    <description>Concentrations of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) in plasma phosphatidylcholine, non-esterified fatty acids, cholesteryl esters and triacylglycerols</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>APOE genotyping</measure>
    <time_frame>Baseline</time_frame>
    <description>APOE genotype determined from blood sample</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anthropometric measurements</measure>
    <time_frame>Baseline</time_frame>
    <description>Height and weight to determine BMI</description>
  </secondary_outcome>
  <enrollment type="Actual">374</enrollment>
  <condition>Plasma Omega-3 Status</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and plasma samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals residing in Southampton, East Anglia, Glasgow and Newcastle
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Exclusion Criteria:

          -  Diagnosed endocrine dysfunction including diabetes

          -  Fasting glucose concentration &gt; 6.5 mmol/L

          -  Myocardial infarction in the previous 2 years

          -  The use of medication that may interfere with lipid metabolism

          -  Fasting total cholesterol of &gt; 8.0 mmol/L

          -  TG of &gt; 3.0 mmol/L

          -  Currently following a weight loss diet

          -  Taking n-3 fatty acid supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Philip C Calder</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Southampton</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Glasgow</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newcastle University</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univeristy of East Anglia</name>
      <address>
        <city>Norwich</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Reading</name>
      <address>
        <city>Reading</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Southampton</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 7, 2017</study_first_submitted>
  <study_first_submitted_qc>August 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2017</study_first_posted>
  <last_update_submitted>August 10, 2017</last_update_submitted>
  <last_update_submitted_qc>August 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>omega-3 status</keyword>
  <keyword>blood lipids</keyword>
  <keyword>Eicosapentaenoic acid (EPA)</keyword>
  <keyword>Docosahexaenoic acid (DHA)</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

